Mini Pharmacy Enterprises, Inc.

Mini Pharmacy Enterprises, Inc. is dedicated to providing diabetes management solutions through innovative medical devices and educational programs, enhancing the quality of life for individuals with diabetes. Founded in 1980, Mini Pharmacy Enterprises, Inc. operates in Los Angeles, US, focusing on diabetes management products.

The company was acquired by Angeles Equity Partners in June 2019, although financial terms were not disclosed. Mini Pharmacy specializes in diabetes management solutions, offering products such as Continuous Glucose Monitors (CGMs), insulin pumps, and blood glucose meters. They also provide a Diabetes Self-Management Training Program to empower patients in managing their condition effectively. Their customer base includes individuals living with diabetes, healthcare providers, and insurance companies, primarily in the United States, where they emphasize high-touch patient care and a seamless customer experience.

Mini Pharmacy generates revenue through direct-to-consumer sales and partnerships with healthcare providers and insurance companies. The firm facilitates the acquisition of CGMs and insulin pumps, supported by its Diabetes Care & Educational Specialists, who assist with coverage verifications. Customers benefit from free shipping on their orders, enhancing the overall offering. While specific pricing information is undisclosed, the revenue model capitalizes on the ongoing demand for diabetes management products and support services.

Mini Pharmacy's future growth strategy includes the design and launch of new diabetes management products, with specific release dates yet to be announced. The company aims to expand its market presence, particularly targeting additional regions within the United States by 2023. The recent acquisition in June 2019 by Angeles Equity Partners is expected to provide the necessary capital and strategic support to facilitate these growth initiatives.